These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9548410)

  • 1. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.
    Nowak G; Legutko B; Skolnick P; Popik P
    Eur J Pharmacol; 1998 Jan; 342(2-3):367-70. PubMed ID: 9548410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment.
    Nowak G; Li Y; Paul IA
    Eur J Pharmacol; 1996 Jan; 295(1):75-85. PubMed ID: 8925878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A partial agonist model used in the allosteric modulation of the NMDA receptor.
    Robichon R; Randall PK; Leslie SW
    Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.
    Paul IA; Layer RT; Skolnick P; Nowak G
    Eur J Pharmacol; 1993 Nov; 247(3):305-11. PubMed ID: 7905831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
    Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
    Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ
    J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.
    Ossowska K; Pietraszek M; Wardas J; Nowak G; Wolfarth S
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):280-7. PubMed ID: 10344526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine.
    De La Garza R; Jentsch JD; Verrico CD; Roth RH
    Brain Res; 2002 Dec; 958(1):20-7. PubMed ID: 12468026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression.
    Harkin A; Nally R; Kelly JP; Leonard BE
    J Neural Transm (Vienna); 2000; 107(10):1213-27. PubMed ID: 11129111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-trans-pyrrolidine-2,4-dicarboxylate and L-threo-3-hydroxyaspartate on the binding of [3H]L-aspartate, [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), [3H]DL-(E)-2-amino-4-propyl-5-phosphono-3-pentenoate (CGP 39653), [3H]6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and [3H]kainate studied by autoradiography in rat forebrain.
    Balcar VJ; Li Y; Killinger S
    Neurochem Int; 1995 Feb; 26(2):155-64. PubMed ID: 7541266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
    Laurie DJ; Seeburg PH
    Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
    Balcar VJ; Dias LS; Li Y; Bennett MR
    Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
    Neijt H; Koller M; Urwyler S
    Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
    Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
    Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
    Grimwood S; Foster AC; Kemp JA
    Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracts from rhizomes of Cyperus articulatus (Cyperaceae) displace [3H]CGP39653 and [3H]glycine binding from cortical membranes and selectively inhibit NMDA receptor-mediated neurotransmission.
    Bum EN; Meier CL; Urwyler S; Wang Y; Herrling PL
    J Ethnopharmacol; 1996 Nov; 54(2-3):103-11. PubMed ID: 8953423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult.
    Dhami KS; Churchward MA; Baker GB; Todd KG
    Mol Cell Neurosci; 2013 Sep; 56():365-74. PubMed ID: 23876875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.